Folic acid, vitamin B12, MTHFR genotypes, and plasma homocysteine [6]

Clinical Chemistry

Volumn 52, Issue 6, 2006, Pages 1205-1206

  Golledge, Jonathan ^a   Jones, Leonie ^a   Oliver, Lisa ^a   Quigley, Francis ^a   Karan, Mirko ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; CYTOSINE; FOLIC ACID; HOMOCYSTEINE; THYMINE;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ALLELE; ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; DIAGNOSTIC VALUE; FEMALE; GENE; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; LEG ISCHEMIA; LETTER; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MTHFR GENE; PERIPHERAL VASCULAR DISEASE; PREDICTION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

AGED; AORTIC ANEURYSM, ABDOMINAL; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; ISCHEMIA; LEG; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PERIPHERAL VASCULAR DISEASES; RISK FACTORS; VITAMIN B 12;

EID: 33646927494     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.069849     Document Type: Letter

References (7)

1. 12 on plasma homocysteine concentrations in hemodialysis patients with known MTHFR genotypes. Clin Chem 2006;52:145-8.
2. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004;291:565-75.
3. B-Vitamin Treatment Trialists' Collaboration. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 2006;151:282-7.
4. Zylberstein DE, Bengtsson C, Bjorkelund C, Landaas S, Sundh V, Thelle D, et al. Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg. Circulation 2004;109:601-6.
5. Golledge J, McCann M, Mangan S, Lam AKY, Karan M. Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke 2004; 35:1636-41.
6. Speirs HJ, Katyk K, Kumar NN, Benjafield AV, Wang WY, Morris BJ. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens 2004;22:931-6.
7. 12 deficiency and hyperhomocysteinemla. Stroke 2006;37: 547-9.